Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
InnoCan Pharma (INNPF) Stock Price & Analysis
11 Followers
INNPF Stock Chart & Stats
Day’s Range$0.21 - $0.21
52-Week Range― - ―
Previous Close$0.23
Volume20.00K
Average Volume (3M)N/A
Market Cap
$55.91M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InnoCan Pharma News
PremiumCompany Announcements
Innocan Pharma Seeks FDA Nod for Pain Therapy
PremiumCompany Announcements
Innocan Pharma’s Revenues Soar in 2023
PremiumCompany Announcements
Innocan Pharma Advances Towards FDA Approval
PremiumCompany Announcements
Innocan Pharma Secures C$2M in Private PlacementPremiumCompany Announcements
Innocan Pharma Advances Neurological Therapies and FundingPremiumCompany Announcements
Innocan Pharma’s LPT-CBD Shows Lasting Effects in Study
Options Prices
Currently, No data available
---
Ownership Overview
24.42% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
75.58% Public Companies and
Individual Investors
INNPF FAQ
What was InnoCan Pharma’s price range in the past 12 months?
Currently, no data Available
What is InnoCan Pharma’s market cap?
Currently, no data Available
When is InnoCan Pharma’s upcoming earnings report date?
InnoCan Pharma’s upcoming earnings report date is May 28, 2024 which is in 32 days.
How were InnoCan Pharma’s earnings last quarter?
InnoCan Pharma released its earnings results on Apr 01, 2024. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is InnoCan Pharma overvalued?
According to Wall Street analysts InnoCan Pharma’s price is currently Overvalued.
Does InnoCan Pharma pay dividends?
InnoCan Pharma does not currently pay dividends.
What is InnoCan Pharma’s EPS estimate?
InnoCan Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InnoCan Pharma have?
Currently, no data Available
What happened to InnoCan Pharma’s price movement after its last earnings report?
InnoCan Pharma reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of InnoCan Pharma?
Currently, no hedge funds are holding shares in INNPF
---
InnoCan Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.80%
12-Months-Change
Fundamentals
Return on Equity
-89.55%
Trailing 12-Months
Asset Growth
-0.52%
Trailing 12-Months
Company Description
InnoCan Pharma
InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.
---
Technical Analysis
---